Latest long-term debt for VAXX: $13M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Vaxxinity (VAXX) currently reports a long-term debt of $13M as of December 2023. That compares with $13M in the prior-year period — up 1.7% year over year. Use the charts on this page to explore Vaxxinity's long-term debt history and peer comparisons.
Vaxxinity's long-term debt increased from $13M to $13M — a 1.7% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Vaxxinity reported $13M in long-term debt as of December 2023. That compares with $13M in the prior-year period — up 1.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vaxxinity, and consider following VAXX for alerts when major investors trade the stock.